Incidence, Pattern and Severity of Adverse Events Following Immunization (AEFIs) Associated With Chadox1 nCOV-19 Corona Virus Vaccine (Recombinant) Among the Healthcare Workers of a Tertiary Care Institute of Eastern Uttar Pradesh, India

Background In January 2020, the Government of India based on the recommendation of the Drugs Controller General of India (DCGI) and National Technical Advisory Group on Immunization (NTAGI) started the rollout of the COVID-19 vaccine in the country. Two vaccines, ChAdOx1 nCoV-19 coronavirus vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamble, Bhushan, Bashar, MD. Abu, Mishra, Chandra Pati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Infectious Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901079/
https://www.ncbi.nlm.nih.gov/pubmed/35273834
http://dx.doi.org/10.7759/cureus.21848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901079/
https://www.ncbi.nlm.nih.gov/pubmed/35273834
http://dx.doi.org/10.7759/cureus.21848

Ejemplares similares